GlassScriptPhysician profile
Kimberly Joshi
NPI 1811295124
$1,679.57
in general payments reported to CMS, 2019-2025
17 companies · $913 in 2025
The $913 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $96.37 · 2023: $39.06 · 2024: $420 · 2025: $913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $477.65 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $221.16 | 2022-2025 | Fasenra, Tezspire, Airsupra |
| Regeneron Healthcare Solutions, INC. | $198.80 | 2024-2025 | Dupixent |
| Novo Nordisk INC | $171.65 | 2021 | |
| Ucb, INC. | $120.65 | 2024 | Nayzilam |
| Immedica Pharma US, INC. | $117.49 | 2024 | |
| Genentech USA, INC. | $75.59 | 2024-2025 | Xolair, Evrysdi |
| Amgen INC. | $68.53 | 2021-2025 | Tezspire |
| Glaxosmithkline, LLC. | $52.83 | 2022-2023 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $30.92 | 2025 | Neffy |
| Csl Behring | $26.02 | 2025 | Hizentra |
| Biocodex, INC. | $24.68 | 2024 | |
| Novartis Pharmaceuticals Corporation | $21.76 | 2022 | |
| Biocryst US Sales Co., LLC | $21.31 | 2025 | Orladeyo |
| Incyte Corporation | $19.51 | 2023 | Opzelura |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $16.77 | 2024 | Daybue |
| Teleflex LLC | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.